US$7.67: That's What Analysts Think TrueBlue, Inc. (NYSE:TBI) Is Worth After Its Latest Results

As you might know, TrueBlue, Inc. (NYSE:TBI) just kicked off its latest quarterly results with some very strong numbers. Results overall were solid, with revenues arriving 5.4% better than analyst forecasts at US$431m. Higher revenues also resulted in substantially lower statutory losses which, at US$0.06 per share, were 5.4% smaller than the analysts expected. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Taking into account the latest results, the most recent consensus for TrueBlue from three analysts is for revenues of US$1.67b in 2026. If met, it would imply a modest 5.7% increase on its revenue over the past 12 months. Earnings are expected to improve, with TrueBlue forecast to report a statutory profit of US$0.42 per share. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$1.68b and earnings per share (EPS) of US$0.48 in 2026. So there's definitely been a decline in sentiment after the latest results, noting the substantial drop in new EPS forecasts.

View our latest analysis for TrueBlue

It might be a surprise to learn that the consensus price target fell 12% to US$7.67, with the analysts clearly linking lower forecast earnings to the performance of the stock price. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. Currently, the most bullish analyst values TrueBlue at US$10.00 per share, while the most bearish prices it at US$6.00. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. For example, we noticed that TrueBlue's rate of growth is expected to accelerate meaningfully, with revenues forecast to exhibit 4.6% growth to the end of 2026 on an annualised basis. That is well above its historical decline of 5.2% a year over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 6.0% per year. Although TrueBlue's revenues are expected to improve, it seems that the analysts are still bearish on the business, forecasting it to grow slower than the broader industry.

The Bottom Line

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for TrueBlue. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. Furthermore, the analysts also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for TrueBlue going out to 2027, and you can see them free on our platform here.

You can also view our analysis of TrueBlue's balance sheet, and whether we think TrueBlue is carrying too much debt, for free on our platform here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.